Increase in PI3K signalling mimics mutated-Kras induction of pancreatic cancer

被引:3
作者
Baer, R. [1 ]
Pyronnet, S. [1 ]
Guillermet-Guibert, J. [1 ]
机构
[1] Univ Toulouse 3, CHU Rangueil, CRCT, INSERM,UMR 1037, F-31432 Toulouse, France
关键词
ADENOCARCINOMA;
D O I
10.1016/j.clinre.2013.04.006
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
[No abstract available]
引用
收藏
页码:320 / 321
页数:2
相关论文
共 3 条
[1]   Both p16Ink4a and the p19Arf-p53 pathway constrain progression of pancreatic adenocarcinoma in the mouse [J].
Bardeesy, N ;
Aguirre, AJ ;
Chu, GC ;
Cheng, KH ;
Lopez, LV ;
Hezel, AF ;
Feng, B ;
Brennan, C ;
Weissleder, R ;
Mahmood, U ;
Hanahan, D ;
Redston, MS ;
Chin, L ;
DePinho, RA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2006, 103 (15) :5947-5952
[2]   Selective Requirement of PI3K/PDK1 Signaling for Kras Oncogene-Driven Pancreatic Cell Plasticity and Cancer [J].
Eser, Stefan ;
Reiff, Nina ;
Messer, Marlena ;
Seidler, Barbara ;
Gottschalk, Kathleen ;
Dobler, Melanie ;
Hieber, Maren ;
Arbeiter, Andreas ;
Klein, Sabine ;
Kong, Bo ;
Michalski, Christoph W. ;
Schlitter, Anna Melissa ;
Esposito, Irene ;
Kind, Alexander J. ;
Rad, Lena ;
Schnieke, Angelika E. ;
Baccarini, Manuela ;
Alessi, Dario R. ;
Rad, Roland ;
Schmid, Roland M. ;
Schneider, Guenter ;
Saur, Dieter .
CANCER CELL, 2013, 23 (03) :406-420
[3]   Prognostic significance of activated Akt expression in pancreatic ductal adenocarcinoma [J].
Yamamoto, S ;
Tomita, Y ;
Hoshida, Y ;
Morooka, T ;
Nagano, H ;
Dono, K ;
Umeshita, K ;
Sakon, M ;
Ishikawa, O ;
Ohigashi, H ;
Nakamori, S ;
Monden, M ;
Aozasa, K .
CLINICAL CANCER RESEARCH, 2004, 10 (08) :2846-2850